Currently submitted to: JMIR Preprints
Date Submitted: Oct 14, 2024
Open Peer Review Period: Oct 14, 2024 - Sep 29, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Conquering Mpox: A Comprehensive Public Health Strategy for Addressing Mpox and Poxvirus Infections in Nigeria – Understanding Global Trends, Transmission Dynamics, and Effective Prevention and Control Measures in Nigeria.
ABSTRACT
Background:
The growing global emphasis on combating infectious diseases has highlighted the need for detailed analyses of outbreak patterns over time. Mpox, formerly known as monkeypox, remains a critical public health challenge in Nigeria, with significant outbreaks occurring between 2017 and 2024. Understanding the trends in Mpox cases, deaths, and geographical spread provides valuable insights into the effectiveness of public health interventions, regional disparities, and demographic vulnerabilities. These findings are essential for informing ongoing and future efforts to mitigate Mpox outbreaks and improve national outbreak preparedness.
Objective:
This study aims to analyze the progression of Mpox outbreaks in Nigeria, focusing on trends in confirmed and suspected cases, deaths, and geographic distribution across states from 2017 to 2024. Additionally, the study explores changes in age and gender-specific vulnerabilities, evaluates the impact of public health interventions, and assesses the reduction in disease burden between 2022 and 2024.
Methods:
A multi-faceted approach was employed, leveraging epidemiological data on Mpox cases from 2017 to 2024. Year-on-year comparisons of confirmed and suspected cases, fatalities, and their geographical distribution were performed to identify trends in disease progression and containment. Geospatial mapping techniques were used to examine regional disparities in Mpox case distribution. Demographic analysis explored shifts in age and gender vulnerabilities, while public health intervention outcomes were assessed based on reductions in cases and geographic spread.
Results:
The comparative analysis from 2017 to 2024 revealed a significant 47% reduction in confirmed Mpox cases between 2023 and 2024, coupled with a notable decrease in both fatalities and geographic spread. Age-based analysis indicated a decline in disease vulnerability across younger age groups, while middle-aged males continued to show a relatively higher infection rate. A dramatic surge in cases occurred in 2022, with 762 confirmed cases, representing the peak of the outbreak. However, cases dropped significantly to 98 in 2023 and further to 40 in 2024, highlighting the success of recent public health interventions. Regional disparities remained evident, with certain states consistently showing higher case burdens, while others experienced reductions in cases, suggesting varied efficacy of local interventions. Geospatial analysis pinpointed persistent hotspots from 2017 to 2022, but a more contained spread was observed in 2023 and 2024. Additionally, gender analysis showed a consistent male predominance in cases across most age groups, with disparities becoming more pronounced in younger populations.
Conclusions:
The sharp reduction in Mpox cases and geographical spread from 2022 to 2024 reflects the positive impact of targeted public health interventions, including vaccination and containment strategies. However, persistent regional and gender disparities suggest that certain populations remain at higher risk, warranting continued monitoring and tailored interventions. Sustained efforts are necessary to prevent future outbreaks, maintain the progress achieved in reducing Mpox cases, and address the factors contributing to these disparities. To further reduce Mpox transmission and prevent future outbreaks, it is essential to strengthen disease surveillance systems in regions identified as consistent hotspots, ensuring rapid detection and response. Public health interventions should be tailored to address gender disparities, particularly the higher infection rates observed among males, while expanding vaccination campaigns and health education initiatives in high-burden areas. Additionally, targeted efforts must investigate the behavioral and biological factors contributing to male vulnerability, especially among younger populations. Sustained focus on these strategies will be critical to maintaining the progress achieved and closing the gaps in disease control. This study provides a comprehensive, multi-year analysis of Mpox outbreaks in Nigeria, offering critical insights into the effectiveness of public health interventions, regional disparities, and demographic trends. The findings underscore the importance of geospatial data in understanding disease distribution and controlling infectious outbreaks. The significant case reduction from 2022 to 2024 highlights the success of ongoing public health measures, while also emphasizing the need for continuous monitoring and adaptive strategies to maintain and further improve disease control.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.